One-Year Outcomes after PCI Strategies in Cardiogenic Shock.

Authors: Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S, CULPRIT-SHOCK Investigators.

The New England journal of medicine. 2018 Nov 1;379(18):1699-1710

Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.

Authors: Ibanez B, Halvorsen S, Roffi M, Bueno H, Thiele H, Vranckx P, Neumann FJ, Windecker S, James S

European heart journal. 2018 Dec 21;39(48):4239-4242

German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock.

Authors: Feistritzer HJ, Desch S, de Waha S, Jobs A, Zeymer U, Thiele H

Clinical research in cardiology : official journal of the German Cardiac Society. 2018 May 16;

CULPRIT-SHOCK (Culprit Lesion Only PCI Versus Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock): Implications on Guideline Recommendations.

Authors: Thiele H, Desch S

Circulation. 2018 Mar 27;137(13):1314-1316

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.

Authors: Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U, CULPRIT-SHOCK Investigators.

The New England journal of medicine. 2017 Dec 21;377(25):2419-2432

Protocol for an economic evaluation of the randomised controlled trial of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: CULPRIT-SHOCK trial.

Authors: Quayyum Z, Briggs A, Robles-Zurita J, Oldroyd K, Zeymer U, Desch S, Waha S, Thiele H

BMJ open. 2017 Aug 18;7(8):e014849

Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial.

Authors: Thiele H, Desch S, Piek JJ, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Noc M, Huber K, Fuernau G, de Waha S, Meyer-Saraei R, Schneider S, Windecker S, Savonitto S, Briggs A, Torremante P, Vrints C, Schuler G, Ceglarek U, Thiery J, Zeymer U, CULPRIT-SHOCK Investigators.

American heart journal. 2016 Feb;172:160-9

CULPRIT-SHOCK Publications